Skip to main content
Top
Published in: Journal of Thrombosis and Thrombolysis 3/2021

Open Access 01-10-2021 | Correction

Correction to: Cardiomyocyte microvesicles: proinflammatory mediators after myocardial ischemia?

Authors: Patrick Malcolm Siegel, Judith Schmich, Georg Barinov, István Bojti, Christopher Vedecnik, Novita Riani Simanjuntak, Christoph Bode, Martin Moser, Karlheinz Peter, Philipp Diehl

Published in: Journal of Thrombosis and Thrombolysis | Issue 3/2021

Login to get access

Excerpt

The article “Cardiomyocyte microvesicles: proinflammatory mediators after myocardial ischemia?”, written by Patrick Malcolm Siegel, Judith Schmich, Georg Barinov, István Bojti, Christopher Vedecnik, Novita Riani Simanjuntak, Christoph Bode, Martin Moser, Karlheinz Peter and Philipp Diehl, was originally published electronically on the publisher’s internet portal on 14 June 2020 without open access. With the author(s)’ decision to opt for Open Choice the copyright of the article changed on 20 May 2021 to © The Author(s) 2021 and the article is forthwith distributed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://​creativecommons.​org/​licenses/​by/​4.​0. …
Metadata
Title
Correction to: Cardiomyocyte microvesicles: proinflammatory mediators after myocardial ischemia?
Authors
Patrick Malcolm Siegel
Judith Schmich
Georg Barinov
István Bojti
Christopher Vedecnik
Novita Riani Simanjuntak
Christoph Bode
Martin Moser
Karlheinz Peter
Philipp Diehl
Publication date
01-10-2021
Publisher
Springer US
Published in
Journal of Thrombosis and Thrombolysis / Issue 3/2021
Print ISSN: 0929-5305
Electronic ISSN: 1573-742X
DOI
https://doi.org/10.1007/s11239-021-02563-8

Other articles of this Issue 3/2021

Journal of Thrombosis and Thrombolysis 3/2021 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.